OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
607855

Value HR Co Ltd

Healthcare Facilities & ServicesVerified

Value HR Co Ltd maintains a liquidity position with a current ratio of 1.02, indicating a balanced short-term liquidity profile, though its free cash flow is negative at -420.91 million JPY, suggesting ongoing capital expenditure pressures. The company's debt-to-equity ratio of 0.74 reflects a moderate leverage position, with long-term debt amounting to 5,085.61 million JPY and total equity at 6,897.50 million JPY. Despite a strong cash and equivalents position of 4,931.03 million JPY, the company's net cash is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, Value HR Co Ltd reports a return on equity of 9.12% and a return on assets of 3.45%, which are key metrics for assessing performance in the Healthcare Facilities & Services industry. These figures suggest the company is generating returns above the industry median, though the exact cohort median is not provided. The operating margin, derived from an operating income of 831.96 million JPY on revenue of 10,068.32 million JPY, indicates a healthy margin profile, though the specific industry benchmark is not disclosed. The company's revenue is not segmented by geographic region or business line in the available data, making it difficult to assess geographic or product concentration risks. However, the absence of detailed segment reporting may obscure potential vulnerabilities in specific markets or product lines. Looking ahead, the company's growth trajectory is influenced by its capital expenditure of -814.97 million JPY and a free cash flow deficit. While the exact outlook for the current and next fiscal years is not provided, the capital outlay suggests a focus on expansion or infrastructure development. The company's risk assessment highlights a medium liquidity risk and a low dilution risk, with no immediate signs of equity dilution pressure. Recent events, including filings and transcripts, are not detailed in the available data, limiting the ability to assess recent strategic or operational developments. The company's financial disclosures do not indicate any material changes in its business model or risk profile in the near term.

30-day price · 6078-119.00 (-8.0%)
Low$1332.00High$1505.00Close$1360.00As of28 May, 00:00 UTC
Profile
CompanyValue HR Co Ltd
Ticker6078.T
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Value HR Co Ltd provides healthcare services and equipment, primarily generating revenue through service provision and product sales.

Classification. Value HR Co Ltd is classified under the Healthcare Facilities & Services industry within the Healthcare Services & Equipment business sector, with a classification confidence of 0.92.

Value HR Co Ltd maintains a liquidity position with a current ratio of 1.02, indicating a balanced short-term liquidity profile, though its free cash flow is negative at -420.91 million JPY, suggesting ongoing capital expenditure pressures. The company's debt-to-equity ratio of 0.74 reflects a moderate leverage position, with long-term debt amounting to 5,085.61 million JPY and total equity at 6,897.50 million JPY. Despite a strong cash and equivalents position of 4,931.03 million JPY, the company's net cash is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, Value HR Co Ltd reports a return on equity of 9.12% and a return on assets of 3.45%, which are key metrics for assessing performance in the Healthcare Facilities & Services industry. These figures suggest the company is generating returns above the industry median, though the exact cohort median is not provided. The operating margin, derived from an operating income of 831.96 million JPY on revenue of 10,068.32 million JPY, indicates a healthy margin profile, though the specific industry benchmark is not disclosed. The company's revenue is not segmented by geographic region or business line in the available data, making it difficult to assess geographic or product concentration risks. However, the absence of detailed segment reporting may obscure potential vulnerabilities in specific markets or product lines. Looking ahead, the company's growth trajectory is influenced by its capital expenditure of -814.97 million JPY and a free cash flow deficit. While the exact outlook for the current and next fiscal years is not provided, the capital outlay suggests a focus on expansion or infrastructure development. The company's risk assessment highlights a medium liquidity risk and a low dilution risk, with no immediate signs of equity dilution pressure. Recent events, including filings and transcripts, are not detailed in the available data, limiting the ability to assess recent strategic or operational developments. The company's financial disclosures do not indicate any material changes in its business model or risk profile in the near term.
Key takeaways
  • Value HR Co Ltd maintains a moderate debt-to-equity ratio of 0.74, indicating a balanced capital structure.
  • The company's return on equity of 9.12% suggests strong profitability relative to its equity base.
  • A negative free cash flow of -420.91 million JPY highlights ongoing capital expenditure pressures.
  • The company's liquidity position is balanced, with a current ratio of 1.02, though net cash is negative after subtracting total debt.
  • The absence of detailed segment reporting limits visibility into geographic or product concentration risks.
  • # RATIONALES
  • {
  • "margin_outlook_rationale": "The company's operating margin is expected to remain stable due to consistent revenue and controlled operating expenses.",
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$10.07B
Gross profit$2.85B
Operating income$832.0M
Net income$629.0M
R&D
SG&A
D&A
SBC
Operating cash flow$1.58B
CapEx-$815.0M
Free cash flow-$420.9M
Total assets$18.22B
Total liabilities$11.32B
Total equity$6.90B
Cash & equivalents$4.93B
Long-term debt$5.09B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$6.90B
Net cash-$154.6M
Current ratio1.0
Debt/Equity0.7
ROA3.5%
ROE9.1%
Cash conversion2.5%
CapEx/Revenue-8.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Biotechnology · cohort 117 companies
Metric6078Activity
Op margin8.3%5.6% medp25 -4.2% · p75 12.6%above median
Net margin6.2%2.8% medp25 -3.4% · p75 8.8%above median
Gross margin28.3%36.5% medp25 23.7% · p75 65.2%below median
CapEx / revenue-8.1%-4.9% medp25 -11.5% · p75 -2.0%below median
Debt / equity74.0%69.3% medp25 7.9% · p75 120.9%above median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-19 15:13 UTC#33ecca4c
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 01:10 UTCJob: 7f46a663